Construction of geldanamycin gene engineering high yield strain
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- MEDICINE & BIOENG INST OF CHINESE ACAD OF MEDICAL SCI
- Publication Date
- 2008-06-11
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
Technical field:
[0001] The invention relates to the application of genetic engineering technology in the construction of antibiotic high-yield bacterial strains. Background technique:
[0002] Geldanamycin (geldanamycin, GDM) producing bacterium-Streptomyces hygroscopicus 17997 (Streptomyces hygroscopicus 17997) is isolated from Chinese soil by the Institute of Pharmaceutical Biotechnology, Chinese Academy of Medical Sciences [Tao Peizhen and other Chinese Journal of Antibiotics, 1997, 22( 5): 368]. Geldanamycin has antitumor and broad-spectrum antiviral effects. Recent studies have shown that GDM can specifically inhibit the function of heat shock protein 90 (Hsp90). Hsp90 is a chaperone molecule for many signaling proteins. GDM can indirectly affect the function of intracellular signaling proteins by inhibiting Hsp90. Therefore, GDM is expected to become a potential anti-tumor and anti-viral drug. The novel mechanism of action of GDM determines the potential scientifi...